在接受ACE抑制剂治疗的患者中,蛇咬后的延迟发作的血管瘤:一个病例报告
Christopher Scott Sampson1, Evan Schwarz2
1University of Missouri School of Medicine, Department of Emergency Medicine, Columbia, Missouri.
Clinical practice and cases in emergency medicine
|August 18, 2023
概括
ангиотензин转化酶抑制剂 (ACEI) 可能会增加患有蛇毒的患者血管的风险. 这一案例凸显了ACEI可能增强毒药效应的潜力,需要提高警.
科学领域:
- 毒理学 毒理学 毒理学
- 药理学 药理学是指药理学的学科.
- 紧急医疗 紧急医疗
背景情况:
- 血管激素转化酶抑制剂 (ACEI) 广泛用于高血压.
- 抗高血压药在治疗蛇毒病中的作用通常不是主要考虑因素.
- 这一案例探讨了ACEI和类动物中毒之间的潜在相互作用.
研究的目的:
- 报告患有血管的病例,该病例发生在患有蛇毒后接受ACEI治疗的患者身上.
- 调查ACEI可能影响蛇反应严重性的潜在机制.
主要方法:
- 一名接受ACEI治疗的65岁男性患者出现了类毒性.
- 患者接受了Crotalidae多价性免疫Fab用于中毒.
- 患者随后出现了血管,需要输管以保护呼吸道.
主要成果:
- 患者在中毒后大约18小时出现了显著的血管功能,包括舌头胀和言语困难.
- 呼吸道保护是必要的,导致输管和机械通风三天.
- 这种不良事件表明ACEI和蛇毒成分之间的潜在相互作用.
结论:
- ACEI可能会增强布拉迪基宁的作用,布拉迪基宁是一种在某些蛇毒中发现的成分.
- ACEI 和来自毒素的布拉迪基宁的联合作用可能会放大血管.
- 临床医生应该对在ACEI治疗中经历了蛇毒的患者的血管发作保持高度警.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
690
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
690
Antihypertensive Drugs: Direct Renin Inhibitors
680
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
680
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
463
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Antihypertensive Drugs: Angiotensin II Receptor Blockers
780
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
780
Acute Kidney Injury IV: Diagnostic Studies and Prevention
34
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
34
Acute Kidney Injury VI: Nursing Management
32
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
32


